多重实时PCR预测淋球菌耐药性的新方法
研究开发了10种改进的分子检测方法,用于直接从核酸扩增试验(NAAT)样本中预测淋球菌对头孢菌素、环丙沙星和阿奇霉素的敏感性。在50份NAAT样本中,预测结果与培养分离株MIC的一致率分别为94%、100%和98%。该方法可扩展用于培养不可用时的耐药监测。
要点
- NAAT-AMR预测与培养MIC一致率:头孢94%、环丙100%、阿奇98%。
- penA A311V或A501加≥2个其他SNP与头孢菌素敏感性降低相关。
- 任何相关SNP存在与环丙沙星或阿奇霉素耐药相关。
核心结论
- 通过增加新位点和多重反应扩展了淋球菌AMR预测的分子检测,以改善培养不可用时的监测。
研究设计与样本
- 开发多重实时PCR检测与头孢菌素、环丙沙星和阿奇霉素耐药相关的SNP,并在127株淋球菌、51株非淋球菌及50份NAAT样本中验证。
主要发现
- 50份NAAT样本的SNP分析与匹配培养RT-PCR分析一致率为96%。
- NAAT-AMR预测与匹配培养的头孢菌素、环丙沙星和阿奇霉素MIC一致率分别为94%、100%和98%。
- penA A311V或A501加≥2个其他SNP与头孢菌素敏感性降低相关,≥3个其他SNP与中介敏感性相关。
- 任何相关SNP存在与环丙沙星或阿奇霉素耐药相关。
临床怎么用
- 可用于直接从NAAT样本预测淋球菌对头孢菌素、环丙沙星和阿奇霉素的敏感性,指导治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence of antimicrobial-resistant Neisseria gonorrhoeae (GC) is rising in Canada; however, antimicrobial resistance (AMR) surveillance data are unavailable for infections diagnosed directly from clinical specimens by nucleic acid amplification tests (NAATs), representing over 80% of diagnoses. We developed a set of 10 improved molecular assays for surveillance of GC-AMR and prediction of susceptibilities in NAAT specimens. METHODS: Multiplex real-time PCR (RT-PCR) assays were developed to detect SNPs associated with cephalosporin (ponA, porB, mtrR -35delA, penA A311V, penA A501, N513Y, G545S), ciprofloxacin (gyrA S91, parC D86/S87/S88) and azithromycin [23S (A2059G, C2611T), mtrR meningitidis-like promoter] resistance. The assays were validated on 127 gonococcal isolates, 51 non-gonococcal isolates and 50 NAATs with matched culture isolates. SNPs determined from the assay were compared with SNPs determined from in silico analysis of WGS data. MICs were determined for culture isolates using the agar dilution method. RESULTS: SNP analysis of the 50 NAAT specimens had 96% agreement with the matched culture RT-PCR analysis. When compared with MICs, presence of penA A311V or penA A501 and two or more other SNPs correlated with decreased susceptibility and presence of three or more other SNPs correlated with intermediate susceptibility to cephalosporins; presence of any associated SNP correlated with ciprofloxacin or azithromycin resistance. NAAT-AMR predictions correlated with matched-culture cephalosporin, ciprofloxacin and azithromycin MICs at 94%, 100% and 98%, respectively. CONCLUSIONS: We expanded molecular tests for N. gonorrhoeae AMR prediction by adding new loci and multiplexing reactions to improve surveillance where culture isolates are unavailable.
引用
- Peterson SW, Martin I, Demczuk W, et al. Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test samples. J Antimicrob Chemother. 2020. PMID: 32830242. doi:10.1093/jac/dkaa360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。